We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Technology Quickly Diagnoses Malaria

By LabMedica International staff writers
Posted on 06 Oct 2016
The gold standard for malaria diagnosis is manual microscopic evaluation of Giemsa stained blood smears; however, the utility of this approach is limited by the skill of an expert microscopist. More...
Further, both the staining process and microscopic examination can be time consuming.

A computerized method has been developed that relies on computers and light-based holographic scans correctly identified malaria-infected cells in a blood sample and this technique does not require any human intervention and could form the basis for a rapid field test for malaria.

A multidisciplinary team of scientists from Duke University (Durham, NC, USA) collected whole blood samples from healthy donors and red blood cells (RBCs) were isolated and purified. RBCs were infected with a Plasmodium falciparum, and synchronized. During the 48-hour life cycle, infected RBCs were isolated from the general RBC population by magnetic sorting via a magnetic cell separation system (MACS, Miltenyi Biotec, Bergisch Gladbach, Germany) to separate uninfected RBCs from those containing parasites. The team used quantitative phase spectroscopy system (QPS) to image red blood cells. Refocused images are analyzed to extract 23 morphological descriptors based on the phase information.

Machine learning algorithms were used to distinguish uninfected RBCs from three different hemozoin containing stages of P. falciparum infected RBCs (early trophozoite–ET, late trophozoite–LT, and schizont–S). All of the classification methods have higher specificities compared to their sensitivities when distinguishing uninfected from infected RBCs for all three stages of infection. The specificities ranged from 98.4% for LT with the early stage of infection (ET) to 100% for the best performing method (LDC) for both LT and S stages.

The authors concluded that one of the main strengths of using machine learning algorithms to analyze the extracted parameters is that the identification of RBC infection will be based on quantified metrics and pre-built classifiers that requires minimal operator training. In order to enable automated imaging in the future, a microfluidic device with controlled flow rates can be combined with the analysis approach that would allow high throughput.

Adam Wax, PhD, a professor of biomedical engineering who helped pioneer the technology, said, “With this technique, the path is there to be able to process thousands of cells per minute. That’s a huge improvement to the 40 minutes it currently takes a field technician to stain, prepare and read a slide to personally look for infection,” The study was published on September 16, 2016, in the journal Public Library of Science ONE.

Related Links:
Duke University
Miltenyi Biotec

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Pipet Controller
Stripettor Pro
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.